Publication date: October 2020Source: Biomedicine & Pharmacotherapy, Volume 130Author(s): Direk Aekthammarat, Panot Tangsucharit, Patchareewan Pannangpetch, Thanaporn Sriwantana, Nathawut Sibmooh
Publication date: October 2020Source: Biomedicine & Pharmacotherapy, Volume 130Author(s): Yijun Chen, Hao Wu, Yueting Li, Jie Liu, Zhixin Jia, Wenjuan Xu, Hongbin Xiao, Wei Wang
Publication date: October 2020Source: Biomedicine & Pharmacotherapy, Volume 130Author(s): Cristiane Maia, Bruno Gonçalves Pinheiro, Carla Cristiane Soares da Silva, Rodrigo A. Cunha, Deiweson Souza-Monteiro, Maria Karolina Martins Ferreira, Tuany Rafaeli Schmidt, Gabriela de Souza Balbinot, Fabrício Mezzomo Collares, Manoela Domingues Martins, Rafael Rodrigues Lima
Publication date: October 2020Source: Biomedicine & Pharmacotherapy, Volume 130Author(s): Chen Huang, Xian Xing, Xinyu Xiang, Xiaoli Fan, Ruoting Men, Tinghong Ye, Li Yang
Publication date: October 2020Source: Biomedicine & Pharmacotherapy, Volume 130Author(s): Fuquan Wang, Shanglong Yao, Haifa Xia
Publication date: October 2020Source: Biomedicine & Pharmacotherapy, Volume 130Author(s): Mohammad Taheri, Reyhane Eghtedarian, Marcel E. Dinger, Soudeh Ghafouri-Fard
Publication date: October 2020Source: Biomedicine & Pharmacotherapy, Volume 130Author(s): Siripong Palee, Louis Higgins, Tom Leech, Siriporn C. Chattipakorn, Nipon Chattipakorn
Publication date: October 2020Source: Biomedicine & Pharmacotherapy, Volume 130Author(s): Seyedeh F. Jafari, Fouad Saleih R. Al-Suede, Ashwaq H.S. Yehya, Mohamed B.K. Ahamed, Armaghan Shafaei, Muhammad Asif, Yasser M. Tabana, Amin M.S.A. Majid, Hussein M. Baharetha
Publication date: October 2020Source: Biomedicine & Pharmacotherapy, Volume 130Author(s): Xiqian Zhang, Ting Wang, Yujie Yang, Ruina Li, Ya Chen, Rong Li, Xuehua Jiang, Ling Wang
Publication date: October 2020Source: Biomedicine & Pharmacotherapy, Volume 130Author(s): Franziska Krautter, Carlota Recio, Mohammed T. Hussain, Danielle R. Lezama, Francesco Maione, Myriam Chimen, Asif J. Iqbal
Publication date: October 2020Source: Biomedicine & Pharmacotherapy, Volume 130Author(s): Soudeh Ghafouri-Fard, Hamed Shoorei, Mohammad Taheri, Marek Sanak
Mark above section as read
Publication date: Available online 7 August 2020Source: BrachytherapyAuthor(s): Daniel Brunnhoelzl, Alexander N. Hanania, Alfredo Echeverria, Jan Sunde, Connie Tran, Michelle Ludwig
Mark above section as read
Publication date: Available online 8 August 2020Source: Clinical TherapeuticsAuthor(s): Eva Peñas-LLedó, Enrique Terán, Marta Sosa-Macías, Carlos Galaviz-Hernández, Jose-Pedro Gil, Sujit Nair, Shyam Diwakar, Isabel Hernández, Julio Lara-Riegos, Ronald Ramírez-Roa, Ignacio Verde, Eduardo Tarazona-Santos, Juan Molina-Guarneros, Graciela Moya, Lembit Rägo, Adrián LLerena
Publication date: Available online 8 August 2020Source: Clinical TherapeuticsAuthor(s): Taixiong Chen, Li Zhou, Ke Wang, Xiao Ma, Haiya Wu, Xin Liu, Jingyu Tong, Bojing Cai, Qiuhe Ji
Publication date: Available online 8 August 2020Source: Clinical TherapeuticsAuthor(s): Turki A. Althunian, Anthonius de Boer, Aukje K. Mantel-Teeuwisse, Rolf H.H. Groenwold, Christine C. Gispen-de Wied, Hubert G.M. Leufkens, Olaf H. Klungel
Publication date: Available online 7 August 2020Source: Clinical TherapeuticsAuthor(s): Stacey Trooskin, Ravi Jhaveri
Publication date: Available online 7 August 2020Source: Clinical TherapeuticsAuthor(s): Lina C. Laxamana, Christian Oliver C. Co, Jeryl Ritzi T. Yu, Christianne V. Mojica, Maria Adelaida M. Iboleon-Dy, Alyssa Mae C. Domingo, Karen Czarina S. Ilano, Ma Cristina Z. Macrohon-Valdez
Mark above section as read
Summary Purpose. A phase I study of intraperitoneal paclitaxel (ip PTX) combined with gemcitabine (GEM) plus nab-paclitaxel (nab-PTX) (GnP) was conducted to determine the maximum tolerated dose (MTD) and the recommended dose (RD) in pancreatic cancer patients with peritoneal metastasis in first-line setting. Methods. Based on the 3 + 3 dose-escalation model, ip PTX, GEM and nab-PTX were administered at doses of 20 or 30 mg/m2, 800 or 1000 mg/m2 and 100 or 125 mg/m2 (level 1, 2...
Summary Purpose Programmed cell death 1 (PD-1), which is upregulated under the continuous induction of the tumor microenvironment, causes chimeric antigen receptor (CAR)-T cell hypofunction via interaction with programmed death ligand 1 (PD-L1). This study aimed to construct CAR-T cells that are resistant to PD-1 inhibition to improve the effect of CAR-T cells in solid tumors. Methods We constructed a type of dual-function CAR-T cell that targets tumor-associated antigen c-Met...
Summary Neuroblastoma (NB) is the most common extracranial solid tumor in children. Under various treatments, some patients still have a poor prognosis. Hence, it is necessary to find new valid targets for NB therapy. In this study, a comprehensive bioinformatic analysis was used to identify differentially expressed genes (DEGs) between NB and control cells, and to select hub genes associated with NB. GSE66586 and GSE78061 datasets were downloaded from the Gene Expression Omnibus...
Summary T cells play crucial roles in the antitumour immune response. However, their dysfunction leads to inefficient tumour eradication. New members of the B7 family have moved to the fore of cancer research because of their involvement in T cell-mediated immune escape and tumorigenesis. Recently, bispecific antibodies (Bi-Abs) have become attractive because of their ability to activate T cells to target tumours. In this study, we examined the expression of new B7 family members...
Summary Naringenin (NG) is a natural antioxidant flavonoid which is isolated from citrus fruits, and has been reported to inhibit colon cancer proliferation. However, the effects of NG treatment on glioma remain to be elucidated. The present study aimed to explore the effects of NG on glioma in vitro and in vivo. Also, the interactions between NG and APO2 ligand (APO2L; also known as tumor necrosis factor-related apoptosis-inducing ligand) were investigated in glioma. A synergistic...
Mark above section as read
Publication date: Available online 8 August 2020Source: Radiotherapy and OncologyAuthor(s): Daniel Moore Freitas Palhares, Gustavo dos Santos Fernandes
Publication date: Available online 8 August 2020Source: Radiotherapy and OncologyAuthor(s): Kenneth Jensen, Jeppe Friborg, Christian Rønn Hansen, Eva Samsøe, Jørgen Johansen, Maria Andersen, Bob Smulders, Elo Andersen, Martin Skovmos Nielsen, Jesper Grau Eriksen, Jørgen Breede Baltzer Petersen, Ulrik Vindelev Elstrøm, Anne Ivalu Holm, Mohammed Farhadi, Morten Hjartdal Morthorst, Peter Sandegaard Skyt, Jens Overgaard, Cai Grau
Publication date: Available online 7 August 2020Source: Radiotherapy and OncologyAuthor(s): Thyrza Z. Jagt, Sebastiaan Breedveld, Rens van Haveren, Ben J.M. Heijmen, Mischa S. Hoogeman
Publication date: Available online 7 August 2020Source: Radiotherapy and OncologyAuthor(s): Cristina Garibaldi, Nuria Jornet, Li Tee Tan, Annette Boejen, Pierfrancesco Franco, Johan Bussink, Esther G.C. Troost, Bartosz Bak, Jean Emmanuel Bibault, Maia Dzhugashvili, Ludwig Van den Berghe, Lara Fizaine, Arta Leci, Umberto Ricardi, Barbara Alicja Jereczek-Fossa
Publication date: Available online 6 August 2020Source: Radiotherapy and OncologyAuthor(s): Josep M. Borras, Rebeca Font, Judit Solà, Miquel Macia, Victòria Tuset, Meritxell Arenas, Arantxa Eraso, Ramona Verges, Nuria Farré, Agustin Pedro, Meritxell Mollà, Manel Algara, Josep M. Solé, Moises Mira, Josep A. Espinàs
Mark above section as read
Publication date: Available online 8 August 2020Source: International ImmunopharmacologyAuthor(s): Pedram Goodarzi, Farzad Mahdavi, Rasoul Mirzaei, Hamze Hasanvand, Mohammad Sholeh, Farhad Zamani, Masodreza Sohrabi, Alireza Tabibzadeh, Ali Salimi Jeda, Mohammad Hadi Karbalaie Niya, Hossein Keyvani, Sajad Karampoor
Publication date: Available online 8 August 2020Source: International ImmunopharmacologyAuthor(s): Marianno Franzini, Luigi Valdenassi, Giovanni Ricevuti, Salvatore Chirumbolo, Markus Depfenhart, Dario Bertossi, Umberto Tirelli
Publication date: November 2020Source: International Immunopharmacology, Volume 88Author(s): Lin Zhu, Haiying Wang, Zuofen Wang
Publication date: November 2020Source: International Immunopharmacology, Volume 88Author(s): Hao Zhou, Haijian Zhang, Muqi Shi, Jinjie Wang, Zhanghao Huang, Jiahai Shi
Publication date: November 2020Source: International Immunopharmacology, Volume 88Author(s): Yuanyuan Liu, Xin Li, Chao He, Ran Chen, Li Wei, Ling Meng, Caiqing Zhang
Publication date: November 2020Source: International Immunopharmacology, Volume 88Author(s): Miao Liu, Wenjie Xie, Xinyue Wan, Tao Deng
Publication date: November 2020Source: International Immunopharmacology, Volume 88Author(s): Kunjiao Xue, Lingying Ruan, Jie Hu, Zhou Fu, Daiyin Tian, Wenjing Zou
Publication date: November 2020Source: International Immunopharmacology, Volume 88Author(s): Mengting Li, Haizhou Wang, Wenjie Li, Yanan Peng, Fei Xu, Jian Shang, Shouquan Dong, Lupin Bu, Hao Wang, Wanhui Wei, Qian Hu, Lan Liu, Qiu Zhao
Publication date: November 2020Source: International Immunopharmacology, Volume 88Author(s): Xuan Deng, Qian Yang, Yuxi Wang, Cheng Zhou, Yi Guo, Zhizhi Hu, Wenhui Liao, Gang Xu, Rui Zeng
Publication date: November 2020Source: International Immunopharmacology, Volume 88Author(s): Mei Guo, Biao Luo, Meng Pan, Miao Li, Hui Xu, Fengshu Zhao, Jun Dou
Publication date: November 2020Source: International Immunopharmacology, Volume 88Author(s): Lei Chen, Wenfeng Xie, Lichun Wang, Xiaofei Zhang, Enhe Liu, Qiuye Kou
Publication date: November 2020Source: International Immunopharmacology, Volume 88Author(s): Xu Zhu, Yazhong Zhang, Huilin Yang, Fan He, Jun Lin
Publication date: Available online 6 August 2020Source: International ImmunopharmacologyAuthor(s): Ming Wu, Jing-jing Ji, Li Zhong, Zi-yun Shao, Qi-feng Xie, Zhe-ying Liu, Cong-lin Wang, Lei Su, Yong-wen Feng, Zhi-feng Liu, Yong-ming Yao
Mark above section as read
Publication date: Available online 7 August 2020Source: Journal of Bodywork and Movement TherapiesAuthor(s): Ravindra C. Thummar, S. Rajaseker, Ranjith Anumasa
Publication date: Available online 7 August 2020Source: Journal of Bodywork and Movement TherapiesAuthor(s): Liliam Fernandes de Oliveira, Hélio V. Cabral, Bruno Felipe Mendonça Leitão, Thiago Torres da Matta
Publication date: Available online 7 August 2020Source: Journal of Bodywork and Movement TherapiesAuthor(s): Sean P. Riley, Jason K. Grimes, Kylie Calandra, Kelsey Foster, Melissa Peet, Matthew T. Walsh
Publication date: Available online 6 August 2020Source: Journal of Bodywork and Movement TherapiesAuthor(s): Brandi Kirk, Teresa Elliott-Burke
Mark above section as read
Publication date: September 2020Source: Photodiagnosis and Photodynamic Therapy, Volume 31Author(s): Kohei Nakajima, Mikako Ogawa
Mark above section as read
Therapeutic Hypothermia and Temperature Management, Ahead of Print.
Mark above section as read
Tissue Engineering Part A, Ahead of Print.
Combined Hydrogel and Mesenchymal Stem Cell Therapy for Moderate-Severity Disc Degeneration in Goats
Tissue Engineering Part A, Ahead of Print.
Tissue Engineering Part A, Ahead of Print.
Tissue Engineering Part A, Ahead of Print.
Mark above section as read
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου